|
SPATA2L expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.304400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.038600E-01 |
| Normal-vs-Stage2 |
5.476800E-01 |
| Normal-vs-Stage3 |
2.863200E-01 |
| Normal-vs-Stage4 |
6.550000E-01 |
| Stage1-vs-Stage2 |
9.789600E-01 |
| Stage1-vs-Stage3 |
1.292210E-02 |
| Stage1-vs-Stage4 |
1.282220E-01 |
| Stage2-vs-Stage3 |
2.478200E-01 |
| Stage2-vs-Stage4 |
4.075600E-01 |
| Stage3-vs-Stage4 |
6.214000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.743800E-01 |
| Normal-vs-AfricanAmerican |
9.839600E-03 |
| Normal-vs-Asian |
2.148000E-01 |
| Caucasian-vs-AfricanAmerican |
6.280300E-03 |
| Caucasian-vs-Asian |
7.470000E-02 |
| AfricanAmerican-vs-Asian |
7.422400E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.378200E-01 |
| Normal-vs-Female |
4.346400E-02 |
| Male-vs-Female |
3.503600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.761800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.841000E-01 |
| Normal-vs-Age(61-80Yrs) |
8.772800E-01 |
| Normal-vs-Age(81-100Yrs) |
4.698600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.413800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.636200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.218800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.530000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.881200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.791200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.321610E-02 |
| Normal-vs-Grade 2 |
1.243550E-01 |
| Normal-vs-Grade 3 |
8.005200E-01 |
| Normal-vs-Grade 4 |
5.377900E-02 |
| Grade 1-vs-Grade 2 |
3.046000E-01 |
| Grade 1-vs-Grade 3 |
6.451800E-02 |
| Grade 1-vs-Grade 4 |
1.636290E-03 |
| Grade 2-vs-Grade 3 |
6.969900E-02 |
| Grade 2-vs-Grade 4 |
8.844300E-04 |
| Grade 3-vs-Grade 4 |
7.933900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.852370E-01 |
| Normal-vs-ccB subtype |
1.041060E-04 |
| ccA subtype-vs-ccB subtype |
4.52689996599531E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.340800E-01 |
| Normal-vs-N1 |
6.764200E-02 |
| N0-vs-N1 |
9.857900E-02 |
|
|
